Fresh Tracks Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Fresh Tracks Therapeutics generated cash of -$4,343,000, which is more than the previous year. Cash used in financing activities reached the amount of $6,531,000 last year. Net change in cash is therefore $2,188,000.
Cash Flow
| 2014 | -9.80M | -12.42M | 3.86M |
|---|---|---|---|
| 2015 | -6.94M | -53K | -20K |
| 2016 | -8.38M | -7.73M | 7.74M |
| 2017 | -8.60M | -5.29M | 30.54M |
| 2018 | 3.96M | -12K | -1.28M |
| 2019 | -35.98M | 32.51M | 2.63M |
| 2020 | -20.03M | 4.47M | 38.44M |
| 2021 | -36.14M | -36K | 32.95M |
| 2022 | -19.33M | -47K | 1.17M |
| 2023 | -4.34M | 0 | 6.53M |
FRTX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 8.68M | 26.88M | 30.11M | 7.23M | 8.06M | 5.39M | 8.38M | 13.45M | 20.47M | 38.83M |
Operating activities | ||||||||||
Net income | -5.69M | -21.10M | -39.47M | -20.91M | -23.87M | -9.23M | -12.96M | -8.97M | -9.23M | -16.49M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 41K | 30K | 22K | 10K | 28K | 49K | 793K | 1.11M | 1.15M | 1.66M |
Stock-based compensation expense | 1.91M | 2.15M | 2.26M | 1.99M | 1.53M | 0 | 756K | 990K | 1.90M | 3.15M |
| Deferred income tax benefit | 1.91M | 2.15M | 2.26M | 1.99M | 1.53M | 0 | 756K | 990K | 1.90M | 3.15M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | -1.97M | -4.58M | -178K | 412K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -165K | -1.03M | 1.02M | -1.67M | -1.82M | 2.84M | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -4.34M | -19.33M | -36.14M | -20.03M | -35.98M | 3.96M | -8.60M | -8.38M | -6.94M | -9.80M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -45.00M | -36.64M | -38.13M | -20.11M | -22.64M |
Investments In Property Plant And Equipment | 0 | -47K | -36K | -23K | -7K | -12K | -80K | -255K | -125K | -354K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | -1.29M | 0 | 0 | 53K | 269K |
Cash generated by investing activities | 0 | -47K | -36K | 4.47M | 32.51M | -12K | -5.29M | -7.73M | -53K | -12.42M |
Financing activities | ||||||||||
Common Stock Issued | 6.56M | 1.19M | 24.00M | 37.97M | 0 | 1K | 30.54M | 7.75M | 3K | 3.92M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -51K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -437K | 2.58M | -1.28M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 6.53M | 1.17M | 32.95M | 38.44M | 2.63M | -1.28M | 30.54M | 7.74M | -20K | 3.86M |
Net Change In Cash | 2.18M | -18.20M | -3.23M | 22.88M | -835K | 2.66M | 16.65M | -8.38M | -7.02M | -18.36M |
Cash at end of period | 10.86M | 8.68M | 26.88M | 30.11M | 7.23M | 8.06M | 25.03M | 5.06M | 13.45M | 20.47M |
| Data source | Data source | Data source | Data source | Data source | Data source |